Sign In
Get Clay Free →

Suggestions

    John Wilson

    Founder and CEO in Cell and Gene Therapy Manufacturing

    John Wilson is a prominent figure in the cell and gene therapy manufacturing industry. Here are the key details about him:

    Professional Background

    John Wilson is the Founder, CEO, and VP of Quality at CellReady, a company he established in May 2023.1 CellReady is designed to accelerate the development of cell and gene therapy (CGT) companies by providing essential resources and expertise.1

    Other Roles and Ventures

    • Wilson Wolf Manufacturing Corporation: Founder and CEO since 1995
    • ScaleReady: Co-Founder and Board Member since January 20201
    • Wilson Foundation Minnesota: Founder and Board Member since 20221

    Expertise and Contributions

    John Wilson has made significant contributions to the field of cell and gene therapy manufacturing:

    • He is known for inventing and developing the G-Rex® technology, widely recognized as a leading platform for cell and gene therapy scale-up and scale-out.
    • Through Wilson Wolf, he has been instrumental in creating devices for various CGT applications, including CAR, CTL, NK, Treg, TIL, and Neo-Antigen therapies.
    • His work aims to simplify and improve the manufacturing processes for cell and gene therapies, making them more practical and cost-effective.23

    Educational Background

    John Wilson holds the following degrees:

    • Mechanical Engineering BS from the University of Minnesota
    • Business Administration BA from Hamline University
    • Economics BA from Hamline University2

    Industry Impact

    Wilson's companies and initiatives have had a significant impact on the CGT industry:

    • ScaleReady, a joint venture he co-founded, focuses on revolutionizing CGT manufacturing.1
    • CellReady aims to cut development time and costs for CGT companies, potentially saving them years and millions of dollars in the process.1
    • He has been involved in launching grant programs to support CGT development and manufacturing, such as the $20 Million G-Rex® Grant Program announced in 2024.4

    John Wilson's LinkedIn username is john-wilson-b778884, as mentioned in the query.

    Highlights

    May 29 · prnewswire.com
    ScaleReady Announces $20 Million G-Rex® Grant Program for the ...
    May 29 · PR Newswire
    ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT ... - PR Newswire
    ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (

    Related Questions

    What inspired John Wilson to start CellReady?
    How does CellReady's G-Rex technology work?
    What are the main challenges John Wilson has faced in the cell and gene therapy industry?
    How does CellReady's business model differ from traditional cell and gene therapy companies?
    What is the significance of the Wilson Foundation for John Wilson's career?
    John Wilson
    John Wilson, photo 1
    John Wilson, photo 2
    Get intro to John
    Add to my network

    Experience

    Founder and CEO at Wilson Wolf Manufacturing Corporation, CellReady, and Wilson Foundation
    Co-Founder and Director at Marker Therapeutics, Co-Founder and Director at AlloVir

    Education

    BS in Mechanical Engineering from University of Minnesota College of Science and Engineering; BA in Business Administration and BA in Economics from Hamline University

    Location

    St Paul, Minnesota, United States